- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03539146
Gastrointestinal Tolerance, Satiation and Sensory Acceptance of Yogurts Containing Dietary Fiber and Coffee Cascara Extract
Gastrointestinal Tolerance, Satiation and Sensory Acceptance of Yogurts Containing Dietary Fiber and Coffee Cascara Extract.
Study Overview
Status
Intervention / Treatment
Detailed Description
Forty healthy volunteers will be recruited and distributed into 4 groups following a randomized, blind, crossover design. Yogurt formulations will be administered two hours after the ingestion of a standardized breakfast, as a snack. Yogurt formulations include:
- Control cascara yogurt with 0% dietary fiber.
- Cascara yogurt with 3% dietary fiber.
- Cascara yogurt with 7% dietary fiber.
- Cascara yogurt with 13% dietary fiber.
The study will be conducted in 4 sessions, with at least 48h of washout period between treatment days. Data on gastrointestinal tolerance, satiation and sensory acceptance will be taken on the same day of the treatment using online surveys.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28049
- Institute of Food Science Research (CIAL-CSIC)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy volunteers.
Exclusion Criteria:
- Food allergies.
- Lactose intolerant.
- Allergic to milk proteins.
- Diagnosed gastrointestinal disease.
- Pregnant, trying to become pregnant or breast feeding.
- Caffeine sensibility.
- Dietary fiber intolerance.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control yogurt
Treatment with a control yogurt with cascara but no dietary fiber.
|
Control yogurt
|
Experimental: Yogurt with fiber
Treatment with yogurts containing cascara and 3%, 7% and 13% of dietary fiber.
|
Intake of yogurt containing cascara with 0%, 3%, 7%,13% dietary fiber in a crossover design.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrointestinal Tolerance
Time Frame: 2 hours after ingestion
|
Self reported gastrointestinal symptoms including bloating, nausea, flatulence, cramping, diarrhea, constipation and rumbling.
Severity of symptoms will be measured with a 4-point scale (0= none, 1= mild, 2=moderate, 3= severe).
|
2 hours after ingestion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satiety
Time Frame: At 0, 15, 60, 115, 125, 150, 180, 210 and 240 minutes after breakfast meal.
|
Self reported sensation of satiety, fullness, thirst, desire to eat food and prospective food consumption.
Measurements will be conducted using a 100mm visual analogue scale (VAS).
|
At 0, 15, 60, 115, 125, 150, 180, 210 and 240 minutes after breakfast meal.
|
Sensory acceptance
Time Frame: up to 5 minutes (At the moment of eating the yogurt)
|
Self reported sensory acceptance of the different yogurts, reporting overall acceptance and liking for the following attributes in a 9 point hedonic scale: appearance, odor, taste and texture.
|
up to 5 minutes (At the moment of eating the yogurt)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maria Dolores del Castillo, PhD, Institute of Food Science Research (CIAL-CSIC)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AGL2014-57239-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Cambridge GlycoscienceCompletedGastrointestinal ToleranceIreland
-
Tate & LyleBiofortis Innovation ServicesCompletedGastrointestinal ToleranceUnited States
-
Abbott NutritionCompletedGastrointestinal ToleranceTurkey
-
Comet Bio Inc.Biofortis, Merieux NutriSciencesUnknownGastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Nutricia ResearchCompletedGastrointestinal TolerancePoland
Clinical Trials on Control yogurt
-
Instituto de Investigación Hospital Universitario...Go Fruselva, S.L.Completed
-
Maastricht University Medical CenterUnknownOverweight and Obesity | Satiety Response | SatiationNetherlands
-
University of ManitobaCompleted
-
Jose María Maya MejíaUnknown
-
University of California, DavisRecruiting
-
BioibericaTechnological Centre of Nutrition and HealthCompletedLow Intensity Knee GonalgiaSpain
-
Micropharma LimitedCompletedHypercholesterolemia
-
Federal University of PelotasPontificia Universidade Católica do Rio Grande do SulCompletedDental Caries | Oral HealthBrazil
-
Instituto de Investigación Hospital Universitario...Completed